Be sure to stop by and explore some of the great offerings, partnership opportunities and promotions we are offering at the show. To schedule a demo or discussion time with a Biomedix representative at the show, please sales@biomedix.com, or call 877-854-0014. …
A recent study published in the Annals of Internal Medicine found that one sixth of patients admitted to a hospital for revascularization for Peripheral Artery Disease (PAD) were readmitted to the hospital within 30 days. Primary reasons were complications, sepsis, and diabetes. …
In a study published in the European Journal of Preventive Cardiology, results indicated that patients with heart disease were hospitalized less if they walked at a faster pace. This study was based on results of 1,078 hypertensive patients, of whom 85% also …
Be sure to visit the SureFit booth, #9, to discover what’s new with PADnet 4.0. PADnet is a critical tool to non-invasively identify peripheral vascular disease. Team with SureFit and PADnet and: Streamline clinical operations via bi-directional HL7 interfaces Save limbs and …
The newest device for front-line PAD diagnostics PADnet 4.0, performs tests faster, is more secure, and is more portable than ever. PADnet enables medical staff familiar with using a blood pressure cuff to generate valuable diagnostic data, including ABIs, TBIs, …
Visit the SureFit booth, #419, to discover what’s new with PADnet 4.0. PADnet is a critical tool to help non-invasively identify peripheral vascular disease. Team with SureFit and PADnet to: Save limbs and save lives by identifying a chronic condition …
Going to DERMfoot 2018? Then look forward to experiencing PADnet 4.0 at the SureFit Booth If you are going to be at the DERMfoot 2018 meeting, stop by the SureFit booth [Booth #F9] to discover all that is new with …